MUNICH--(BUSINESS WIRE)--Daiichi Sankyo Europe, (hereafter, Daiichi Sankyo) today announced results from two prespecified analyses from the Phase 3 CLEAR (Cholesterol Lowering via Bempedoic Acid, an ...
CEDHARS is pleased to announce the recipients of its spring 2023 pilot grant funding opportunity, “Secondary Data Analysis to Advance Health or Rehabilitation Outcomes Research in People with ...
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19) Clinical trials frequently ...
This secondary data review template is an indicative template which can be customized based on the operational needs that are clarified in the assessment objectives and defined more clearly in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results